Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children
Anand Kawade, Girish Dayma, Aditi Apte, Nilima Telang, Meenakshi Satpute, Emma Pearce, Lucy Roalfe, Rakesh Patil, Yanyun Wang, Navideh Noori, Arun Gondhali, Sanjay Juvekar, Assaf P. Oron, Sonali Sanghavi, David Goldblatt, Ron Dagan, Ashish Bavdekar
Research output: Contribution to journal › Article › peer-review
3Scopus
citations
Fingerprint
Dive into the research topics of 'Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children'. Together they form a unique fingerprint.